Atazanavir

Atazanavir is an antiretroviral medication used to treat HIV infection. It is a protease inhibitor and works by blocking the protease enzyme, which the HIV virus needs to multiply. By blocking this enzyme, Atazanavir prevents the virus from replicating and reduces the amount of virus in the body. This can help to improve the immune system and reduce the risk of developing opportunistic infections. Atazanavir is usually prescribed in combination with other medications to achieve the best results.

Atazanavir, sold under brand names like Reyataz and Evotaz, is an antiretroviral medication used in combination therapy to treat HIV/AIDS.

Here's a breakdown of its key points:

  • Function: Atazanavir belongs to a class of drugs called protease inhibitors. It works by blocking an enzyme crucial for HIV replication, preventing the virus from multiplying and causing further damage.
  • Dosage: It's typically taken once daily by mouth, with food, and often combined with other antiretroviral medications for optimal efficacy.
  • Suitability: Atazanavir is generally recommended for adults and children (3 months and older, weighing at least 5 kg) with HIV infection. In some cases, it may be used for post-exposure prophylaxis (PEP) after potential HIV exposure.

It's important to remember that:

  • Atazanavir doesn't cure HIV, but it can significantly reduce the viral load and delay the progression of HIV/AIDS.
  • It should always be taken as prescribed by your doctor and not be stopped without consulting them.
  • Atazanavir can have potential side effects, so it's crucial to discuss them with your doctor before starting the medication.

Disclaimer: I am not a medical professional, and this information should not be taken as medical advice. Always consult with your doctor for any questions or concerns you may have regarding Atazanavir or any other medical treatment.

Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AE Protease inhibitors
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
External Links